Warning: This security is no longer trading.
UCB Completes the Acquisition of Ra Pharmaceuticals
Ra Pharmaceuticals, Inc. (RARX): Price and Financial Metrics
RARX Price/Volume Stats
| Current price | $48.00 | 52-week high | $48.02 |
| Prev. close | $48.01 | 52-week low | $19.64 |
| Day low | $47.98 | Volume | 3,864,600 |
| Day high | $48.01 | Avg. volume | 1,158,500 |
| 50-day MA | $46.43 | Dividend yield | N/A |
| 200-day MA | $39.47 | Market Cap | 2.27B |
RARX Stock Price Chart Interactive Chart >
Ra Pharmaceuticals, Inc. (RARX) Company Bio
Ra Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of novel therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system. Its peptide chemistry platform delivers enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules. The company was founded in 2008 and is based in Cambridge, Massachusetts.
RARX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 2.61% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | 157.86% |
Continue Researching RARX
Here are a few links from around the web to help you further your research on Ra Pharmaceuticals Inc's stock as an investment opportunity:Ra Pharmaceuticals Inc (RARX) Stock Price | Nasdaq
Ra Pharmaceuticals Inc (RARX) Stock Quote, History and News - Yahoo Finance
Ra Pharmaceuticals Inc (RARX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...